BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30410860)

  • 1. Both Ser361 phosphorylation and the C-arrestin domain of thioredoxin interacting protein are important for cell cycle blockade at the G1/S checkpoint.
    Kamitori K; Yamaguchi F; Dong Y; Hossain A; Katagi A; Noguchi C; Hirata Y; Tsukamoto I; Hatano N; Tokuda M
    FEBS Open Bio; 2018 Nov; 8(11):1804-1819. PubMed ID: 30410860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare sugar D-allose induces specific up-regulation of TXNIP and subsequent G1 cell cycle arrest in hepatocellular carcinoma cells by stabilization of p27kip1.
    Yamaguchi F; Takata M; Kamitori K; Nonaka M; Dong Y; Sui L; Tokuda M
    Int J Oncol; 2008 Feb; 32(2):377-85. PubMed ID: 18202760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins.
    Patwari P; Chutkow WA; Cummings K; Verstraeten VL; Lammerding J; Schreiter ER; Lee RT
    J Biol Chem; 2009 Sep; 284(37):24996-5003. PubMed ID: 19605364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioredoxin-Interacting Protein in Cancer and Diabetes.
    Masutani H
    Antioxid Redox Signal; 2022 May; 36(13-15):1001-1022. PubMed ID: 34384271
    [No Abstract]   [Full Text] [Related]  

  • 5. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
    Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I
    Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.
    Hsieh YH; Su IJ; Wang HC; Tsai JH; Huang YJ; Chang WW; Lai MD; Lei HY; Huang W
    Mol Cancer Res; 2007 Oct; 5(10):1063-72. PubMed ID: 17951406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 mitogen-activated protein kinase contributes to cell cycle regulation by cAMP in FRTL-5 thyroid cells.
    Corrèze C; Blondeau JP; Pomérance M
    Eur J Endocrinol; 2005 Jul; 153(1):123-33. PubMed ID: 15994754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous hydrogen sulfide-mediated MAPK inhibition preserves endothelial function through TXNIP signaling.
    Tian D; Dong J; Jin S; Teng X; Wu Y
    Free Radic Biol Med; 2017 Sep; 110():291-299. PubMed ID: 28669627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA; DeLorenzo RJ; Tombes RM
    Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
    Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.
    Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
    Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK-dependent proteasome degradation of Txnip regulates thioredoxin oxidoreductase activity.
    Kelleher ZT; Wang C; Forrester MT; Foster MW; Marshall HE
    J Biol Chem; 2019 Sep; 294(36):13336-13343. PubMed ID: 31320475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.
    Tomoda K; Kubota Y; Kato J
    Nature; 1999 Mar; 398(6723):160-5. PubMed ID: 10086358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare sugar D-allose enhances anti-tumor effect of 5-fluorouracil on the human hepatocellular carcinoma cell line HuH-7.
    Yamaguchi F; Kamitori K; Sanada K; Horii M; Dong Y; Sui L; Tokuda M
    J Biosci Bioeng; 2008 Sep; 106(3):248-52. PubMed ID: 18930000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
    Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.